Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Clinical trial NCT05938946 · COMPLETED

Trial details

NCT number: NCT05938946
Sponsor: Pharmosa Biopharm Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2023-08-30
Primary completion: 2024-09-02
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.